Application progress of spatial omics in hepatobiliary tumor research.
0/5 보강
APA
Du L, Yi H, Xu H (2025). Application progress of spatial omics in hepatobiliary tumor research.. Hepatobiliary surgery and nutrition, 14(6), 1028-1030. https://doi.org/10.21037/hbsn-2025-aw-862
MLA
Du L, et al.. "Application progress of spatial omics in hepatobiliary tumor research.." Hepatobiliary surgery and nutrition, vol. 14, no. 6, 2025, pp. 1028-1030.
PMID
41383666 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Porphy-based drug-delivery nanoparticles for photodynamic therapy and photoactivated cascade chemotherapy.
- Clinical and immunological significance of FOXO1 as a biomarker of improved response to immune checkpoint plus tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma.
- Risk factors for early mortality (within 6 weeks of diagnosis) in Chinese children with acute leukemia: a single-center retrospective cohort study.
- TTPAL inhibits the progression of breast cancer and reprograms tumor-associated macrophages by inhibiting JAK2/STAT3 signaling pathway.
- Effect of a goal-directed composite insulation scheme on perioperative elderly patients undergoing laparoscopic colorectal cancer surgery: study protocol for a randomized controlled trial.
📖 전문 본문 읽기 PMC JATS · ~9 KB · 영문
Supplementary
Supplementary
The article’s supplementary files as
The article’s supplementary files as
출처: PubMed Central (JATS). 라이선스는 원 publisher 정책을 따릅니다 — 인용 시 원문을 표기해 주세요.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Spatial omics at the forefront: emerging technologies, analytical innovations, and clinical applications.
- Intra-procedural Cone-Beam Computed Tomography for Ultrasound-Guided Microwave Ablation of Hepatocellular Carcinoma: An Initial Experience.
- Matrix Metalloproteinases in Hepatocellular Carcinoma: Mechanistic Roles and Emerging Inhibitory Strategies for Therapeutic Intervention.
- Hepatocellular Carcinoma in Egypt in the Post HCV Elimination Era: Changing Aetiology, Surveillance, and Management Pathways.
- DDX17-mediated raptor-dependent mTORC1 activation links autophagy inhibition and metabolic compensation in HCC development.
- Combinatorial treatment with donafenib and quercetin suppresses lipid metabolism in HepG2 cells by targeting the CREB1/DRP1/SREBP1 axis.